Paper32761968
Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer.
Ryu JS and 11 others. Cancer Sci, 2020. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer. Papers, record 32761968. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32761968
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| BRCA1 Protein | Major topic |
| Breast Neoplasms | Major topic |
| Neoplasm Proteins | Major topic |
| Ovarian Neoplasms | Major topic |
| Adult | |
| Checkpoint Kinase 2 | |
| Exons | |
| Fanconi Anemia Complementation Group Proteins | |
| Female | |
| Germ-Line Mutation | |
| Humans | |
| Middle Aged | |
| Mismatch Repair Endonuclease PMS2 | |
| RNA Helicases |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| NCC-1611161 | National Cancer Center | Republic of Korea | PubMed | |
| 2018R1A6A3A01012838 | Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education | PubMed | ||
| 2020R1A2C2010566 | National Research Foundation of Korea (NRF) funded by the Korean government (MSIT) | PubMed |
Source PubMed
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28970858 | A Novel Germline Mutation in BRCA1 Causes Exon 20 Skipping in a Korean Family with a History of Breast Cancer. | J Breast Cancer | 2017 | https://conductscience.org/library/papers/28970858 | PubMed |
| 2 | 21365267 | PALB2 mutations in familial breast and pancreatic cancer. | Fam Cancer | 2011 | https://conductscience.org/library/papers/21365267 | PubMed |
| 3 | 32761968 | Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer. | Cancer Sci | 2020 | https://conductscience.org/library/papers/32761968 | PubMed |
| 4 | 18628483 | A novel breast cancer-associated BRIP1 (FANCJ/BACH1) germ-line mutation impairs protein stability and function. | Clin Cancer Res | 2008 | https://conductscience.org/library/papers/18628483 | PubMed |
| 5 | 25099582 | PALB2 mutations and breast-cancer risk. | N Engl J Med | 2014 | https://conductscience.org/library/papers/25099582 | PubMed |
| 6 | 31822495 | Rare BRIP1 Missense Alleles Confer Risk for Ovarian and Breast Cancer. | Cancer Res | 2020 | https://conductscience.org/library/papers/31822495 | PubMed |
| 7 | 20215541 | A high proportion of DNA variants of BRCA1 and BRCA2 is associated with aberrant splicing in breast/ovarian cancer patients. | Clin Cancer Res | 2010 | https://conductscience.org/library/papers/20215541 | PubMed |
| 8 | 29680930 | Splicing mutations in human genetic disorders: examples, detection, and confirmation. | J Appl Genet | 2018 | https://conductscience.org/library/papers/29680930 | PubMed |
| 9 | 27834932 | Functional Studies and In Silico Analyses to Evaluate Non-Coding Variants in Inherited Cardiomyopathies. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/27834932 | PubMed |
| 10 | 27153395 | Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer. | Am J Hum Genet | 2016 | https://conductscience.org/library/papers/27153395 | PubMed |
| 11 | 29271107 | Optimizing the identification of risk-relevant mutations by multigene panel testing in selected hereditary breast/ovarian cancer families. | Cancer Med | 2018 | https://conductscience.org/library/papers/29271107 | PubMed |
| 12 | 26270727 | Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment. | JAMA Oncol | 2015 | https://conductscience.org/library/papers/26270727 | PubMed |
| 13 | 24733792 | Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment. | J Clin Oncol | 2014 | https://conductscience.org/library/papers/24733792 | PubMed |
| 14 | 30244837 | The BRCT Domains of the BRCA1 and BARD1 Tumor Suppressors Differentially Regulate Homology-Directed Repair and Stalled Fork Protection. | Mol Cell | 2018 | https://conductscience.org/library/papers/30244837 | PubMed |
| 15 | 30982232 | Germline mutation landscape of Chinese patients with familial breast/ovarian cancer in a panel of 22 susceptibility genes. | Cancer Med | 2019 | https://conductscience.org/library/papers/30982232 | PubMed |
| 16 | 27268795 | The Ensembl Variant Effect Predictor. | Genome Biol | 2016 | https://conductscience.org/library/papers/27268795 | PubMed |
| 17 | 11984562 | Polygenic susceptibility to breast cancer and implications for prevention. | Nat Genet | 2002 | https://conductscience.org/library/papers/11984562 | PubMed |
| 18 | 20644199 | The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. | Genome Res | 2010 | https://conductscience.org/library/papers/20644199 | PubMed |
| 19 | 28413668 | PALB2 mutation in a woman with bilateral breast cancer: A case report. | Mol Clin Oncol | 2017 | https://conductscience.org/library/papers/28413668 | PubMed |
| 20 | 30686823 | Strategies for Improving Access to Hereditary Cancer Testing: Recommendations from Stakeholders. | Genet Med | 2019 | https://conductscience.org/library/papers/30686823 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42433780 | The role of non-coding variants in hereditary cancer syndromes: mechanistic insights and clinical implications. | Ann Med Surg (Lond) | 2026 | https://conductscience.org/library/papers/42433780 | PubMed |
| 41035082 | Mono-allelic MUTYH mutation as the likely inherited etiology of hereditary breast cancer in a patient from a multi-cancer family- report of a family and literature review. | BMC Med Genomics | 2025 | https://conductscience.org/library/papers/41035082 | PubMed |
| 41011238 | The Role of Non-Coding Regions in Breast Cancer: From Gene Regulation to Therapeutic Implications. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41011238 | PubMed |
| 40956513 | Prevalence of germline CHEK2 variants in East Asians and Koreans based on population genomic databases. | Breast Cancer | 2026 | https://conductscience.org/library/papers/40956513 | PubMed |
| 38254803 | Prevalence and Distribution of MUTYH Pathogenic Variants, Is There a Relation with an Increased Risk of Breast Cancer? | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38254803 | PubMed |
| 34846068 | Splicing predictions, minigene analyses, and ACMG-AMP clinical classification of 42 germline PALB2 splice-site variants. | J Pathol | 2022 | https://conductscience.org/library/papers/34846068 | PubMed |
| 34809663 | Six splice site variations, three of them novel, in the ABO gene occurring in nine individuals with ABO subtypes. | J Transl Med | 2021 | https://conductscience.org/library/papers/34809663 | PubMed |
| 34424438 | Understanding the Clinical Implications of Low Penetrant Genes and Breast Cancer Risk. | Curr Treat Options Oncol | 2021 | https://conductscience.org/library/papers/34424438 | PubMed |
| 33893081 | Clinical Utility of Functional RNA Analysis for the Reclassification of Splicing Gene Variants in Hereditary Cancer. | Cancer Genomics Proteomics | 2021 | https://conductscience.org/library/papers/33893081 | PubMed |
| 32761968 | Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer. | Cancer Sci | 2020 | https://conductscience.org/library/papers/32761968 | PubMed |
Genes34
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32761968
GET https://conductscience.org/api/papers/v1/32761968/references?page=2